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Available online 22 March 2016Background: Single exposure to remote ischaemic pre-conditioning (RIPC) has been shown to be effective in
reducing major adverse events during cardiac surgery. We evaluated the efﬁcacy of repeated exposure RIPC to
elicit improvements in cardiovascular function.
Methods: A systematic search was conducted up until May 1st, 2015, using the following databases: EMBASE,
PubMed (Medline), Web of Science and the Cochrane Central Registry of Controlled Trials (CENTRAL). Data
was extracted and synthesized from published studies of repeat RIPC.
Results: Data from seven studies showed evidence of improvements in vascular function and anti-hypertensive
effects of systolic, diastolic and mean arterial blood pressure following repeat RIPC. Currently existing work jus-
tiﬁes a systematic reviewbut not data pooling of individual studydata. Repeat RIPC has also produced evidence of
improvements in endothelial dependent vasodilation, but not non-endothelial dependent vasodilation, cutane-
ous vascular conductance or cardiorespiratory ﬁtness.
Conclusion: Repeated RIPC exposure has produced evidence of improvements in endothelial dependent vasodi-
lation, ulcer healing and bloodpressure but nobeneﬁt in non-endothelial dependent vasodilation, cutaneous vas-
cular conductance or cardiorespiratory ﬁtness. The optimal delivery of RIPC remains unclear, but at least 3 or
preferably 4, 5 min exposures appears to be most beneﬁcial, at least for reducing blood pressure. Aside from
those undertaking cardiac surgery, other study populations with endothelial dysfunction may beneﬁt from re-
peat exposure to RIPC.
© 2016 TheAuthors. Published by Elsevier Ireland Ltd. This is an openaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Remote ischaemic pre-conditioning (RIPC) relates to short sequences
of ischaemia, usually 4–5 min, of repeated blood pressure cuff inﬂation
and deﬂation on a limb. Short periods of ischaemia trigger cellular signal-
ling pathways that protect against a subsequent longer period of ischae-
mia, such as during percutaneous coronary intervention (PCI). RIPC is
an effective technique for protecting the heart against ischaemia reperfu-
sion injury because short periods of ischaemia triggers cellular signalling
pathways that protect against a subsequent longer period of ischaemia.
The RIPC process usually involves 3–4 cycles of 5min of cuff inﬂation
at 200mmHg, interspersed with 5min of deﬂation, total exposure lasts
about 35 min [1]. RIPC has become increasingly attractive because it is
relatively simple to administer and is non-invasive and safe. Moreover
RIPC can be administered during natural waiting periods as patients
enter theatre for cardiac surgery. RIPC has been used in both upper
and lower limbs and the primary use has offer cardio-protection for
those undergoing percutaneous coronary revascularization [2]. RIPC
has also been found to reduce acute kidney injury in those exposed toland Ltd. This is an open access articlcontrastmedia [3,4] and reduce, in acute cases, infarction size by admin-
istering RIPC during transport to themedical centre prior to cardiac sur-
gery [5]. More recent work has examined the cumulative effects of
repeated RIPC treatments to manage blood pressure [6], improve endo-
thelial function and blood ﬂow [7].
The effects of RIPC extend beyond the tissues exposed to cuff occlu-
sion, with recent reports suggesting a neuroprotective effect that im-
proves tolerance to cerebral ischaemia [8]. RIPC induces sustained
neuroprotection attenuating adenosine 5′-monophosphate-activated
protein kinase [9]. RIPCmay therefore improve impaired cognitive func-
tion in those with known cardiovascular or metabolic disease [10]. The
exact mechanism via which RIPC exerts beneﬁts remains unknown but
may be related to changes with the autonomic nervous system and dif-
fusible factors [6].
Meta-analyses examined the beneﬁts of a single exposure (3–
4 cycles) to ischaemic pre-conditioning for people undertaking PCI, re-
ductions in measures of myocardial infarct size and prevalence of acute
kidney injury [11,12]. The beneﬁts of single RIPC exposure appears
however to be bi-phasic with a short initial window of protection in
the ﬁrst 12 h, followed by a period of no protection and ﬁnally a longer
window of protection lasting as long as 72 h after exposure [6]. Recent
work has therefore intuitively examined the potential beneﬁts ofe under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
56 J. Epps et al. / IJC Heart & Vasculature 11 (2016) 55–58repeated sessions of remote RIPC, administered over weeks or months,
for improving several aspects of cardiovascular health. Repeated RIPC
exposure serves possibly two purposes; ﬁrst the ‘topping up’ of RIPC
protection during the unprotected period; second, repeated RIPC may
provide a cumulative protective effect that cannot be achieved with a
single exposure. To date only a handful of studies of repeated sessions
of remote RIPC exist and the primary outcomemeasures have been var-
ied. The efﬁcacy of this new approach therefore has yet to be fully
explored.
The aims of this work were to conduct a systematic review, and
where appropriate, meta-analysis, to (i) examine the effects of repeated
exposure to bouts of remote RIPC on a range of cardiovascular health in-
dicators; and (ii) relate the ﬁndings to established thresholds of clinical
signiﬁcance.
2. Methods
2.1. Search strategy
To identify potential studies, systematic searches were carried out
using the following databases: EMBASE, PubMed (Medline),Web of Sci-
ence and the Cochrane Central Registry of Controlled Trials (CENTRAL).
The search was supplemented by scanning the reference lists of eligible
studies. The search strategy included the key concepts of: repeat remote
ischaemic preconditioning, remote ischaemic conditioning, ischaemic
preconditioning, physiological ischaemia training, limb occlusion and cuff
inﬂation. All identiﬁed papers were assessed independently by two
reviewers. A third reviewer was consulted to resolve disputes. Searches
of published papers were conducted up until January 7th, 2016.
2.2. Inclusion/exclusion criteria
Any trial designs of repeated, remote ischaemic pre-conditioning, of
at least 7 days duration, were included. Study populations included
were adults (N18 years) without known cardiac disease. There were
no language restrictions. Animal studies and review papers were ex-
cluded. Studies that included participants who were treated by other
pharmaceutical or surgical modalities such as coronary artery bypass
grafting were excluded. Authors were contacted to be given the oppor-
tunity to providemissing data or to clarify if datawas duplicated inmul-
tiple publications. Incomplete data, or data from an already included
study, were excluded. Studies that included interventions other than re-
peat remote ischaemic pre-conditioning were excluded.
2.3. Participants/population
This systematic review analysed published studies of both male and
female adults (≥18 years)with andwithout known coronary artery dis-
ease. Studies of non-repeat RIPC treatmentmodalities and interventions
were excluded.
2.4. Intervention(s), exposure(s)
This systematic review considered all trials where participants were
exposed to repeat, remote ischaemic pre-conditioning.More speciﬁcally
all published trials where the intervention of expanding a blood pres-
sure cuff ormedical tourniquet in a remote limbwas carried out on a re-
peated basis.
2.5. Comparator(s)/control
The systematic review and meta-analysis utilised studies that com-
pared repeat remote ischaemic conditioning with control or repeated
sham remote ischaemic conditioning.2.6. Outcome(s)
The primary outcomes discussed will be:
1. Blood pressure.
2. Blood ﬂow.
3. Endothelial progenitor Cell (EPC) concentrations.
4. Other beneﬁts e.g. wound healing.
2.7. Search results
Initially 792 papers were identiﬁed by database searching, a further
20 potential papers were by scrutinizing reference lists of identiﬁed pa-
pers. Of the 812 papers found, 102 were review articles, 703 were not
RIPC trials in humans. Only 7 human trials of repeat RIPC exposure
were found.
2.8. Strategy for data synthesis
A descriptive analysis of extracted data was undertaken.
3. Results
Data from eight published studies were extracted and synthesized.
4 were cases studies [6,13–15], 3 were RCT's [7,16,17] and 1 cohort
study [18]. Study duration varied from 1 to 8 weeks. Repeat RIPC proto-
cols varied from 1 to 4 cycles of 5 min occlusion, cuff inﬂation was sim-
ilar across studies 200–220 mm Hg, and frequency of administration
was 1 or 2 times daily. Details of programme characteristics are
described in Table 1. A lack of sufﬁciently similar outcome measures
between studies precluded data pooling for meta-analyses.
3.1. Blood pressure
Four case studies reported variable changes in systolic and diastolic
blood pressures after repeat RIPC [6,13–15]. These 4 studies, all by the
same author, each used repeated, periodic, blood pressure measures to
conﬁrm the ﬁndings. Madias reported 6 mm Hg and 3 mm Hg falls in
systolic and diastolic pressure, respectively, with twice daily repeat
RIPC [13]. Madias and Koulouridis slightly reﬁned his methods and
noted a short-lived fall of 5mmHg in SBP [15]. In 2015,Madias reported
a 6.1mmHg reduction in SBP, a 3.7mmHg change in pulse pressure, but
no signiﬁcant change in DBP, after twice daily, 15-min repeat RIPC ses-
sions for 10 days [6]. Madias's later work in 2015 showed no change in
SBP, DBP, pulse pressure and heart rate; this study used once-daily re-
peat RIPC sessions [14]. Kimura et al.'s work was the only RCT to report
blood pressure and they showed no change after 4 weeks repeat RIPC,
but they only measured blood pressure during the experiment and not
at other times [16]. Theworks of Madias and Kimura provide conﬂicting
evidence of a sustained reduction in blood pressure. The 7-day study of
repeat RIPC by Jones et al. reported a 5mmHg reduction inmean arterial
pressure in the intervention arm8days post-intervention, but again am-
bulatory blood pressures were not recorded [18].
3.2. Vascular function
Kimura et al. reported that repeat RIPC augments endothelium-
dependent vasodilation and also production of nitric oxide [16].
Serum levels of vascular endothelial growth factor (VEGF) were in-
creased by 33.9% and this correlated with an improvement in endothe-
lial progenitor cells after repeat RIPC intervention. An increase in
endothelial progenitor cells by 23.9% was also reported.
Similarly Jones et al. [18] reported improved ﬂow-mediated dilata-
tion (FMD) and cutaneous vascular conductance in their 7-day study
of repeat RIPC. The same authors showed sustained improvement in
FMD at 8 weeks, but did not report improved cutaneous vascular
Table 1
Published studies of repeated exposure to remote ischaemic pre-conditioning.
Study Design Weeks Protocol Frequency Comparator No.
participants
Outcome measure
Jones 2014a [18] Cohort 1 4 × 5
220 mm Hg
5 min reperfusion
1× daily None 13 healthy Flow mediated dilatation
C vascular conductance
Shear
Mean arterial pressure
Jones 2014b [7] RCT 8 4 × 5min
220 mm Hg
5 min reperfusion
3× weekly Control 18 healthy
(9 RIPC)
Flow mediated dilatation
Vascular conductance
Peak VO2
Shear
Mean arterial pressure
Kimura 2007 [16] RCT 4 1 × 5 200 mm Hg 6× daily Control 20 healthy
(10RIPC)
Forearm blood ﬂow
Endothelial progenitor cells
Systolic blood pressure
Diastolic blood pressure
Heart Rate
Madias 2011 [13] Case study 3 days RIPC
with pre- and
post-observation
3 × 5min at 20 mm Hg above
SBP with 5 min reperfusion
2× daily None 1 Repeat blood pressure measures
Madias 2014 [15] Case study 7 days RIPC with pre-
and post-observation
3 × 5min at 20 mm Hg above
SBP with 5 min reperfusion
2× daily None 1 Repeat blood pressure measures
Madias 2015a [6] Case study 10 days 3 × 5 2× daily Self 1 Repeat blood pressure measures
Madias 2015b [14] Case study 10 days 3 × 5 1× daily Self 1 Repeat blood pressure measures
Shaked 2015 [17] RCT 6 weeks 3 × 5 Bi-weekly Sham 40 Diabetic ulcer healing
57J. Epps et al. / IJC Heart & Vasculature 11 (2016) 55–58conductance, brachial artery diameter or shear rate. In contrast to
Kimura et al.'s work [16], Jones et al. [18] reported an improvement in
endothelial function in both the exposed and contra-lateral arm in
their 7-day work. Kimura et al. also reported an increase in Acetylcho-
line induced forearm blood ﬂow by 35.5% [16].
3.3. Cardiorespiratory ﬁtness
The 8-week study by Jones reported no change in peak VO2 follow-
ing repeat RIPC [7].
3.4. Wound healing
The largest RCT to date focussed on wound healing in diabetic pa-
tients and showed signiﬁcant improvements in diabetic foot ulcers [17].
3.5. Effect of study duration and residual effects
It appears that anti-hypertensive and endothelial function beneﬁts
are possible with repeated exposure to RIPC within 7 days [18]. The
work of Jones et al. suggests that some beneﬁts of repeat RIPC may
peak after 1 week but sustained beneﬁts from continued RIPC exposure
can be retained for at least 8 days after repeat RIPC exposure [7].
4. Discussion
Our systematic review reveals that few published studies of repeat
exposure to RIPC exist to date; however, this intervention shows early
promise as a treatment for vascular dysfunction. Insufﬁcient data cur-
rently exists to justify data pooling, but individual studies have reported
anti-hypertensive effects of systolic, diastolic and mean arterial blood
pressure following repeat RIPC. Repeat RIPC has also produced evidence
of improvements in endothelial dependent vasodilation, but not non-
endothelial dependant vasodilation, cutaneous vascular conductance
or cardiorespiratory ﬁtness.
The works of Madiasmay indicate that twice-daily exposure to RIPC
may be required to lower blood pressure [6,14]. Madias' ﬁndings are
countered by those of Kimura et al. [16], but the former did take numer-
ous repeated, but not ambulatory, blood pressure measurements while
the latter relied on a single measurement. The works of Jones et al. [18]
support Madias' claim of blood pressure reduction within 7 days [6].Jones et al.'s 8-week study [7] also support Madias' notion that anti-
hypertensive effects aremaintained for several days after RIPC exposure
has ceased [6]. A possible explanation for conﬂicting blood pressure
ﬁndings are that Kimura et al. [16] only used 1 × 5min RIPC bouts, al-
though thesewere applied 6 times daily, both Jones et al. [7] andMadias
and Koulouridis [15] used the 3 or 4 × 5min RIPC protocols and both
showed BP reduction whereas Kimura et al. did not. Kimura et al. used
more frequent RIPC applications, but it therefore appears that the aggre-
gate repeated exposure of 15–20min per application is more important
than frequency, at least for initiating blood pressure reductions. As
Madias used ambulatory measurements, which are usually considered
more robust and therefore less likely to showblood pressure reductions,
it is unlikely that Kimura et al.'s use of single blood pressure measure-
ments would explain why the former showed reductions but the latter
did not. One other possible explanation is that Kimura et al. used a stan-
dard 200 mm Hg inﬂation pressure, while others used 220 mm Hg or
20 mmHg above systolic pressure. It is possible that subjects in Kimura
et al.'s study had either resting systolic pressures elevated above
200mmHgor they experienced agonal responses elevating their systol-
ic pressures beyond 200 mm Hg, although this is unlikely.
The study by Shaked et al. [17] showed improved diabetic ulcer
healing compared to control in the largest repeat RIPC trial to date.
Moreover, the degree of wound granulation increased after just one
cycle of treatment in one third of diabetic treated compared to only
19% in the control group. Shaked et al.'swork perhaps opens up the pos-
sibility for treatment of peripheral arterial diseasewith repeat RIPC [19].
Kimura et al.'s work perhaps indicates that exposure to repeated
bouts of RIPC improves endothelial function, but not non-endothelial de-
pendent vasodilation, nor vascular smooth muscle performance [16].
Moreover, the improved endothelial function may be due to increased
systemic nitric oxide concentrations which are at least partially due to
an increase in endothelial progenitor cells. It appears that the vascular
shear stress that results from repeat exposure to RIPC causes two events;
Firstly, increases in availability of nitric oxide, which may explain initial
protection against ischaemic reperfusion injury. Secondly, a delayed in-
crease in the presence of endothelial progenitor cells, some of which dif-
ferentiate to form haematopoietic cells, explains the second phase of
protection against ischaemic reperfusion injury [20,21]. Also, related
to hypoxic processes is an increase in VEGF which is up-regulated by
HIF-1 alpha and contributes to increasing levels of EPCs and therefore
improved capillary density and nitric oxide availability [16].
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Themajor limitation of this work is the small sample sizes in studies,
aside from one RCT in diabetic patients, published to date [17]. Another
signiﬁcant limitation is that the protocols for implementing the repeat-
ed RIPC across studies varied greatly, although itwas also a strength as it
enabled characteristics of different protocols to be related to the pres-
ence or absence of beneﬁcial changes e.g. reduced blood pressure.
It is unclear whether study size of 18–20 RIPC participants is sufﬁ-
cient to detect changes in blood pressure or othermarkers of endothelial
function. Forty participants was however, sufﬁcient to detect changes in
ulcer healing in diabetic patients [17]. In contrast, the 4 case studies in a
single individual by Madias provided numerous blood pressure mea-
surements that would be considered robust enough to meet the desired
gold standard of ambulatory blood pressure measurement.
The short study durations of the two published RCTs are 4 and
8 weeks [7]. There are several limitations of these published works to
date. First, it is unclear whether beneﬁts are intermittent, as studies of
single exposure to RIPC have suggested a bi-modal effectwith awindow
12–24 h after exposure. It is therefore unclearwhether a twice-daily ap-
proach is optimal for ‘closing this window’ as Jones et al. [7] used once
daily and Kimura et al. six daily RIPC exposures [16]. Second, although
Jones et al. reported sustained beneﬁts up to 8 days post-intervention
[7], it is unclear exactly how long the beneﬁts of RIPC last.
4.2. Implications for future research
Futurework should give consideration to the clinical problems, sam-
ple characteristics and methodological issues. The implications for re-
search are that administration of repeated RIPC in large numbers of
people is time intensive. One solution to this is commercially available
devices but these are costly NUS$2K per patient. Manual administration
of cuff inﬂation can also be prone to error as some cuffs leak. In terms of
the study populations there does not appear to be safety issues for high
risk populations based upon single exposure studies in cardiac and renal
patients and a recent repeat RIPC exposure study has reported ulcer
healing beneﬁts in diabetes patients [17]. Perhaps the most important
message though for future study design is to ensure each RIPC session
has at least 3 or preferably 4, 5 min exposures. Compared to 3–4 expo-
sures, a single 5min exposure appears less beneﬁcial for reducing blood
pressure, even if the single exposure is provided several times daily [16].
Until now the focus of single exposure RIPC has been upon those un-
dergoing cardiac surgery and repeat exposure has focused on hyperten-
sive populations. Other populations exhibiting endothelial dysfunction,
for example people with diabetes [19] or pulmonary hypertension [22]
may beneﬁt most from repeated exposure to RIPC.
Twice daily repeat RIPC administration, separated by 12 h, may
‘close’ the window of exposure to ischaemic reperfusion injury in
those at risk. However, as the timing of RIPC administration is para-
mount, it appears that only those people undertaking elective cardiac
surgery may derive most beneﬁt as the optimal timing of RIPC delivery
may not be possible with emergency surgery.
5. Conclusions
Repeated RIPC exposure has produced some evidence of improve-
ments in endothelial dependent vasodilation, ulcer healing and blood
pressure but not non-endothelial dependent vasodilation, cutaneous
vascular conductance or cardiorespiratory ﬁtness. The optimal delivery
of RIPC remains unclear, but compared to 3–4 exposures, a single 5 min
exposure appears less beneﬁcial for reducingblood pressure. Aside from
those undertaking cardiac surgery, other study populations with endo-
thelial dysfunction may beneﬁt from repeat exposure to RIPC.Acknowledgements
None.References
[1] C.E. Murry, R.B. Jennings, K.A. Reimer, Preconditioning with ischemia: a delay of
lethal cell injury in ischemic myocardium, Circulation 74 (5) (1986) 1124–1136.
[2] Z. Liu, Y.L. Wang, Q. Hua, Y.Y. Chu, X.M. Ji, Late remote ischemic preconditioning pro-
vides beneﬁt to patients undergoing elective percutaneous coronary intervention,
Cell Biochem. Biophys. 70 (1) (2014) 437–442.
[3] T. Yamanaka, Y. Kawai, T. Miyoshi, T. Mima, K. Takagaki, S. Tsukuda, Y. Kazatani, K.
Nakamura, H. Ito, Remote ischemic preconditioning reduces contrast-induced
acute kidney injury in patients with ST-elevation myocardial infarction: a random-
ized controlled trial, Int. J. Cardiol. 178 (2015) 136–141.
[4] F. Er, A.M. Nia, H. Dopp, M. Hellmich, K.M. Dahlem, E. Caglayan, T. Kubacki, T.
Benzing, E. Erdmann, V. Burst, et al., Ischemic preconditioning for prevention of con-
trast medium-induced nephropathy: randomized pilot RenPro trial (renal protec-
tion trial), Circulation 126 (3) (2012) 296–303.
[5] H.E. Botker, R. Kharbanda, M.R. Schmidt, M. Bottcher, A.K. Kaltoft, C.J. Terkelsen, K.
Munk, N.H. Andersen, T.M. Hansen, S. Trautner, et al., Remote ischaemic condition-
ing before hospital admission, as a complement to angioplasty, and effect on myo-
cardial salvage in patients with acute myocardial infarction: a randomised trial,
Lancet 375 (9716) (2010) 727–734.
[6] J.E. Madias, Sustained blood pressure lowering effect of twice daily remote ischemic
conditioning sessions in a normotensive/prehypertensive subject, Int. J. Cardiol. 182
(2015) 392–394.
[7] H. Jones, J. Nyakayiru, T.G. Bailey, D.J. Green, N.T. Cable, V.S. Sprung, N.D. Hopkins,
D.H. Thijssen, Impact of eight weeks of repeated ischaemic preconditioning on bra-
chial artery and cutaneous microcirculatory function in healthy males, Eur. J. Prev.
Cardiol. (2014).
[8] S.V. Narayanan, K.R. Dave, M.A. Perez-Pinzon, Ischemic preconditioning and clinical
scenarios, Curr. Opin. Neurol. 26 (1) (2013) 1–7.
[9] V.R. Venna, J. Li, S.E. Benashski, S. Tarabishy, L.D. McCullough, Preconditioning in-
duces sustained neuroprotection by downregulation of adenosine 5′-
monophosphate-activated protein kinase, Neuroscience 201 (2012) 280–287.
[10] Y.S. Kim, S.C. Davis, J. Truijen, W.J. Stok, N.H. Secher, J.J. van Lieshout, Intensive
blood pressure control affects cerebral blood ﬂow in type 2 diabetes mellitus
patients, Hypertension 57 (4) (2011) 738–745.
[11] H. Pei, Y. Wu, Y. Wei, Y. Yang, S. Teng, H. Zhang, Remote ischemic preconditioning
reduces perioperative cardiac and renal events in patients undergoing elective cor-
onary intervention: a meta-analysis of 11 randomized trials, PLoS One 9 (12)
(2014), e115500.
[12] L. Yang, G. Wang, Y. Du, B. Ji, Z. Zheng, Remote ischemic preconditioning reduces
cardiac troponin I release in cardiac surgery: a meta-analysis, J. Cardiothorac. Vasc.
Anesth. 28 (3) (2014) 682–689.
[13] J.E. Madias, Effect of serial arm ischemic preconditioning sessions on the systemic
blood pressure of a normotensive subject, Med. Hypotheses 76 (4) (2011) 503–506.
[14] J.E. Madias, Absence of a sustained blood pressure lowering effect of once daily re-
mote ischemic conditioning sessions in a normotensive/prehypertensive subject,
Int. J. Cardiol. 184 (2015) 307–309.
[15] J.E. Madias, I. Koulouridis, Effect of repeat twice daily sessions of remote ischemic
conditioning over the course of one week on blood pressure of a normotensive/
prehypertensive subject, Int. J. Cardiol. 176 (3) (2014) 1076–1077.
[16] M. Kimura, K. Ueda, C. Goto, D. Jitsuiki, K. Nishioka, T. Umemura, K. Noma, M.
Yoshizumi, K. Chayama, Y. Higashi, Repetition of ischemic preconditioning aug-
ments endothelium-dependent vasodilation in humans: role of endothelium-
derived nitric oxide and endothelial progenitor cells, Arterioscler. Thromb. Vasc.
Biol. 27 (6) (2007) 1403–1410.
[17] G. Shaked, D. Czeiger, A. Abu Arar, T. Katz, I. Harman-Boehm, G. Sebbag, Intermittent
cycles of remote ischemic preconditioning augment diabetic foot ulcer healing,
Wound Repair Regen. 23 (2) (2015) 191–196.
[18] H. Jones, N. Hopkins, T.G. Bailey, D.J. Green, N.T. Cable, D.H. Thijssen, Seven-day re-
mote ischemic preconditioning improves local and systemic endothelial function
and microcirculation in healthy humans, Am. J. Hypertens. 27 (7) (2014) 918–925.
[19] S.Y. Wang, F.S. Xue, X.L. Cui, Comparing cardioprotection by remote ischaemic pre-
conditioning in patients with and without diabetes, Acta Anaesthesiol. Scand. 58 (6)
(2014) 768.
[20] J.D. Stroncek, B.S. Grant, M.A. Brown, T.J. Povsic, G.A. Truskey, W.M. Reichert, Com-
parison of endothelial cell phenotypic markers of late-outgrowth endothelial pro-
genitor cells isolated from patients with coronary artery disease and healthy
volunteers, Tissue Eng. A 15 (11) (2009) 3473–3486.
[21] M. Cheng, X. Guan, H. Li, X. Cui, X. Zhang, X. Li, X. Jing, H. Wu, E. Avsar, Shear stress
regulates late EPC differentiation via mechanosensitive molecule-mediated cyto-
skeletal rearrangement, PLoS One 8 (7) (2013), e67675.
[22] S. Hu, F. Li, H. Luo, Y. Xia, J. Zhang, R. Hu, G. Cui, H. Meng, H. Feng, Amelioration of
rCBF and PbtO2 following TBI at high altitude by hyperbaric oxygen pre-
conditioning, Neurol. Res. 32 (2) (2010) 173–178.
